Prospective study of risk factors for Alzheimer's disease: Results at 7.5 years

American Journal of Psychiatry

Volumn 156, Issue 1, 1999, Pages 50-57

  Zubenko, George S ^a   Winwood, Ethel ^b   Jacobs, Barbara ^b   Teply, Ivana ^b   Stiffler, J Scott ^b   Hughes III, Hugh B ^b   Huff, Jacob ^b   Sunderland, Trey ^b   Martinez, A Julio ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1,6 DIPHENYL 1,3,5 HEXATRIENE; MEMBRANE PROTEIN;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEMBRANE FLUIDITY; PRIORITY JOURNAL; RATING SCALE; RELATIVE; RISK FACTOR; THROMBOCYTE MEMBRANE;

EID: 0032898055     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.156.1.50     Document Type: Article

References (81)

1. Zubenko GS, Cohen BM, Growden J, Corkin S: Cell membrane abnormality in Alzheimer's disease (letter). Lancet 1984; 2:235
2. Zubenko GS, Cohen BM, Reynolds CF III, Boller F, Malinakova I, Keefe N: Platelet membrane fluidity in Alzheimer's disease and major depression. Am J Psychiatry 1987; 144:860-868
3. Hicks N, Brammer MJ, Hymas N, Levy R: Platelet membrane properties in Alzheimer and multi-infarct dementias. Alz Dis Assoc Disord 1987; 1(suppl 2):90-97
4. Eagger S, Hajimohammadreza I, Fletcher K, Levy R, Brammer M: Platelet membrane fluidity, family history, and severity and age of onset in Alzheimer's disease. Int J Geriatr Psychiatry 1990; 5:395-400
5. Hajimohammadreza I, Brammer MJ, Eagger S, Burns A, Levy R: Platelet and erythrocyte membrane changes in Alzheimer's disease. Biochim Biophys Acta 1990; 1025:208-214
6. Piletz JE, Sarasua M, Whitehouse P, Chotani M: Intracellular membranes are more fluid in platelets of Alzheimer's disease patients. Neurobiol Aging 1991; 12:401-406
7. van Rensburg SJ, Carstens ME, Potocnik FCV, Aucamp AK, Taljaard JF, Koch KR: Membrane fluidity of platelets and erythrocytes in patients with Alzheimer's disease and the effect of small amounts of aluminum on platelet and erythrocyte membranes. Neurochem Res 1992; 17:825-829
8. Kálmán J, Dey I, Ilona SV, Matkovics B, Brown D, Janka Z, Farkas T, Joó F: Platelet membrane fluidity and plasma malondialdehyde levels in Alzheimer's demented patients with and without family history of dementia. Biol Psychiatry 1994; 35:190-194
9. Zubenko GS: Biological correlates of clinical heterogeneity in primary dementia. Neuropsychopharmacology 1992; 6(suppl 2):77-93
10. Zubenko GS, Huff FJ, Beyer J, Auerbach J, Teply I: Familial risk of dementia associated with a biologic subtype of Alzheimer's disease. Arch Gen Psychiatry 1988; 45:889-893
11. Zubenko GS, Brenner RP, Teply I: Electroencepholographic correlates of increased platelet membrane fluidity in Alzheimer's disease. Arch Neurol 1988; 45:1009-1013
12. Zubenko GS, Brenner RP, Teply I: Risk factors for stroke as predictors of platelet membrane fluidity in Alzheimer's disease. Stroke 1991; 22:997-1003
13. Zubenko GS, Teply I: Longitudinal study of platelet membrane fluidity in Alzheimer's disease. Biol Psychiatry 1988; 24:918-924
14. Zubenko GS, Wusylko M, Cohen BM, Boller F, Teply I: Family study of platelet membrane fluidity in Alzheimer's disease. Science 1987; 238:539-542
15. Chakravarti A, Slaugenhaupt SA, Zubenko GS: Inheritance pattern of platelet membrane fluidity in Alzheimer's disease. Am J Hum Genet 1989; 44:799-805
16. Zubenko GS, Malinakova I, Chojnacki B: Proliferation of internal membranes in platelets from patients with Alzheimer's disease. J Neuropathol Exp Neurol 1987; 46:407-418
17. Cohen BM, Zubenko GS, Babb SM: Abnormal platelet membrane composition in Alzheimer's-type dementia. Life Sci 1987; 40:2445-2451
18. Zubenko GS: Endoplasmic reticulum abnormality in Alzheimer's disease: selective alteration in platelet NADH-cytochrome C reductase activity. J Geriatr Psychiatry Neurol 1989; 2:3-10
19. Noguchi S, Murakami K, Yamada N: Apolipoprotein E genotype and Alzheimer's disease (letter). Lancet 1993; 342:737
20. Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-McLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD: Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43:1467-1472
21. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD: Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993; 90:1977-1981
22. Ueki A, Kawano M, Namba Y, Kawakami M, Ikeda K: A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci Lett 1993; 163:166-168
23. Chartier-Harlin M-C, Parfitt M, Legrain S, Perez-Tur J, Brousseau T, Evans A, Berr C, Vidal O, Roques P, Gourle V, Fruchart J-C, Delacourte A, Rossor M, Amouyel P: Apolipoprotein E, ε4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994; 3:569-574
24. Dai XY, Nanko S, Hattori M, Fukuda R, Nagata K, Isse K, Ueki A, Kazamatsuri H: Association of apolipoprotein E4 with sporadic Alzheimer's disease is more pronounced in early onset type. Neurosci Lett 1994; 175:74-76
25. Yoshizawa T, Yamakawkobayashi K, Komatsuzaki Y, Arinami T, Oguni E, Mizusawa H, Shoji S, Hamaguchi H: Dose-dependent association of apolipoprotein E allele epsilon 4 with late-onset, sporadic Alzheimer's disease. Ann Neurol 1994; 36: 656-659
26. Zubenko GS, Stiffler S, Stabler S, Kopp U, Hughes HB, Cohen BM, Moossy J: Association of the apolipoprotein E ε4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease. Am J Med Genet Neuropsychiatr Genet 1994; 54:199-205
27. Hendrie HC, Hall KS, Hui S, Unverzagt FW, Yu CE, Lahiri DK, Sahota A, Farlow M, Msick B, Class CA: Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann Neurol 1995; 37:118-120
28. Maestre G, Ottman R, Stern Y, Gurland B, Chun M, Tang MX, Shelanski M, Tycko B, Mayeux JR: Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol 1995; 37:254-259
29. Myklebost O, Rogne S: A physical map of the apolipoprotein gene cluster on human chromosome 19. Hum Genet 1988; 78:244-247
30. Zubenko GS, Teply I, Winwood E, Huff FJ, Moossy J, Sunderland T, Martinez AJ: Prospective study of increased platelet membrane fluidity as a risk factor for Alzheimer's disease: results at five years. Am J Psychiatry 1996; 153:420-423
31. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261:921-923
32. Payami H, Montee KR, Kaye JA, Bird TD, Yu C-E, Wijsman EM, Schellenberg GD: Alzheimer's disease, apolipoprotein ε4, and gender. JAMA 1994; 271:1316-1317
33. Rebeck GW, Reiter JS, Strickland DK, Hyman BT: Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993; 11:575-580
34. Zubenko GS: Molecular neurobiology of Alzheimer's disease (syndrome?). Harvard Rev Psychiatry 1997; 5:177-213
35. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD: Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993; 90:9649-9653
36. Petersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid DJ, Thibodeau SN, Kokmen E, Waing SC, Kurland L: Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995; 273: 1274-1278
37. Myers RH, Schaefer EJ, Wilson PWF, D'Agostino R, Ordovas JM, Espino A, Au R, White RF, Knoefel JE, Cobb JL, McNulty KA, Beiser A, Wolf PA: Apolipoprotein E ε4 association with dementia in a population-based study: the Framingham study. Neurology 1996; 46:673-677
38. Heston LL, Mastri AR, Anderson VE, White J: Dementia of the Alzheimer type: clinical genetics, natural history, and associated conditions. Arch Gen Psychiatry 1981; 38:1085-1090
39. Heyman A, Wilkinson WE, Hurwitz BJ, Schmechel D, Sigmon AH, Weinberg T, Helms MJ, Swift M: Alzheimer's disease: genetic aspects and associated clinical disorders. Ann Neurol 1983; 14:507-515
40. Breitner JCS, Murphy EA, Folstein MF: Familial aggregation in Alzheimer dementia, II: clinical genetic implications of age-dependent onset. J Psychiatr Res 1986; 20:45-55
41. Mohs RC, Breitner JCS, Silverman JM, Davis KL: Alzheimer's disease: morbid risk among first-degree relatives approximates 50% by 90 years of age. Arch Gen Psychiatry 1987; 44: 405-408
42. Huff FJ, Auerbach J, Chakravarti A, Boller F: Risk of dementia in relatives of patients with Alzheimer's disease. Neurology 1988; 38:786-790
43. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944
44. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
45. Mattis S: Mattis Organic Mental Syndrome Screening Examination (MOMSSE), in Geriatric Psychiatry: A Handbook for Psychiatrists and Primary Care Physicians. Edited by Bellak L, Karasu TB. New York, Grune & Stratton, 1976, pp 102-177
46. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140:566-572
47. Tomlinson BE, Corsellis JAN: Aging and the dementias, in Greenfield's Neuropathology, 4th ed. Edited by Adams HJ, Corsellis JAN, Duchen LW. New York, John Wiley & Sons, 1984, pp 951-1025
48. Khachaturian ZS: Diagnosis of Alzheimer's disease. Arch Neurol 1985; 42:1097-1105
49. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41:479-486
50. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1988; 16:1215
51. Zubenko GS, Stiffler S, Farr J, Kopp U, Hughes H, Kaplan BB, Moossy J: Lack of variation in the nucleotide sequence corresponding to the transmembrane domain of the β-amyloid precursor protein in Alzheimer's disease. Am J Med Genet Neuropsychiatr Genet 1993; 48:131-136
52. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990; 31:545-548
53. Amaducci L, Lippi A: Risk factors for dementia, in Dementia. Edited by Burns A, Levy R. London, Chapman & Hall, 1994, pp 129-141
54. Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R: Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 1994; 271:1004-1010
55. Canadian Study of Health and Aging: Risk factors for Alzheimer's disease in Canada. Neurology 1994; 44:2073-2080
56. Fratiglioni L, Grut M, Forsell Y, Vitanen M, Grafstrom M, Holmém K, Ericsson K, Backman L, Ahlbom A, Winblad B: Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology 1991; 41:1886-1892
57. Beard CM, Kokmen E, Offord KP, Kurland LT: Lack of association between Alzheimer's disease and education, occupation, marital status, or living arrangement. Neurology 1992; 42:2063-2068
58. Chartier-Harlin M-C, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Roques P, Hardy J, Mullan M: Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 1991; 353:844-846
59. Goate AM, Chartier-Harlin CM, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704-706
60. Murrell J, Farlow M, Ghetti B, Benson MD: A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 1991; 254:97-99
61. Mullan M, Crawford F, Axelman K, Houlden H, Lulius L, Winblad B, Lannfelt L: A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nature Genet 1992; 1:345-347
62. Schellenberg GD, Bird TD, Wijsman EM, Orr HT, Anderson L, Nemens E, White JA, Bonnycastle L, Weber JL, Alonso ME, Potter H, Heston LL, Martin GM: Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 1992; 58:668-671
63. St George-Hyslop P, Haines J, Rogaev E, Mortilla M, Vaula G, Pericak-Vance M, Foncin J-F, Montesi M, Bruni A, Sorbi S: Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat Genet 1992; 2:330-334
64. van Broeckhoven C, Backhovens H, Cruts M, de Winter G, Bruyland M, Cras P, Martin JJ: Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3. Nat Genet 1992; 2:335-339
65. Nechiporuk A, Fain P, Kort E, Nee LE, Frommelt E, Polinsky RJ, Korenberg JR, Pulst SM: Linkage of familial Alzheimer disease to chromosome 14 in 2 large early-onset pedigrees: effects of marker allele frequencies on LOD scores. Am J Med Genet 1993; 48:63-66
66. Alzheimer's Disease Collaborative Group: The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nat Genet 1995; 11:219-222
67. Campion D, Flaman J-M, Brice A, Hennequin D, Dubois B, Martin C, Moreau V, Charbonnier F, Didierjean O, Tardieu S, Penet C, Puel M, Pasquier F, LeDoze F, Bellis G, Calenda A, Heilig R, Martinez M, Mallet J, Bellis M, Clerget-Darpoux F, Agid Y, Frebourg T: Mutations of the presenilin 1 gene in families with early-onset Alzheimer's disease. Hum Mol Genet 1995; 4:2373-2377
68. Cruts M, Backhovens H, Wang S-Y, Gassen GV, Theuns J, DeJonghe C, Wehnert A, DeVoecht J, DeWinter G, Cras P, Bruyland M, Datson N, Weissenbach J, den Dunnen JT, Martin J-J, Hendriks L, van Broeckhoven C: Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3. Hum Mol Genet 1995; 4:2363-2371
69. Sherrington R, Govaev EI, Liang Y, Rogaeva EA, Levesque G, Ikdea M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin J-F, Bruni AC, Montesi MP, Sorbi S, Rainero I, Piness L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, DaSilva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375:754-760
70. Sahara N, Yahagi Y-I, Takagi H, Kondo T, Okochi M, Susami M, Shirasawa T, Mari H: Identification and characterization of presenilin I-467, I-463, and I-374. FEBS Lett 1996; 381:7-11
71. Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard KAB, Weber JLJ, Bird TD, Schellenberg GD: A familial Alzheimer's disease locus on chromosome 1. Science 1995; 269:970-972
72. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu C-E, Jondro PD, Schmidt SD, Wang K, Crowley AC, Fu Y-H, Guenette SY, Galas D, Nemens E, Wijsman EM, Bird TD, Schellenberg GD, Tanzi RE: Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 269:973-977
73. Rogaev El, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holamn K, Tsuda T, Mar L, Sorbi S, Nacmias B, Piacentini S, Amaducci L, Chumaker I, Cohen D, Lannfelt L, Fraser PE, Rommens JM, St George-Hyslop PH: Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995; 376:775-778
74. Holland AJ: Down's syndrome and dementia of the Alzheimer type, in Dementia. Edited by Burns A, Levy R. London, Chapman & Hall, 1994, pp 695-708
75. Pericak-Vance MA, Bebout JL, Gaskell PC, Yamaoka LH, Hung WY, Alberts MJ, Walker AP, Bartlett RJ, Haynes CA, Welsh KA, Earl NL, Heyman A, Clark CM, Roses AD: Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet 1991; 8:1034-1050
76. Pericak-Vance MA, Bass MP, Yamaoka LH, Gaskell PC, Scott WK, Terwedow HA, Menold MM, Conneally PM, Small GW, Vance JM, Saunders AM, Roses AD, Haines JL: Complete genomic screen in late-onset familial Alzheimer disease. JAMA 1997; 278:1237-1241
77. Zubenko GS, Stiffler JS, Hughes HB, Hurtt MR, Kaplan BB: Initial results of a genome survey for novel Alzheimer's disease risk genes: association with a locus on the X chromosome. Am J Med Genet Neuropsychiatr Genet 1998; 81:98-107; correction, 81:196-205
78. Zubenko S, Hughes HB, Stiffler JS, Hurtt MR, Kaplan BB: A genome survey for novel Alzheimer's disease risk loci: results at 10cM resolution. Genomics 1998; 50:121-128
79. Hutchin TP, Heath PR, Pearson RCA, Sinclair AJ: Mitochondrial DNA mutations in Alzheimer's disease. Biochem Biophys Res Comm 1997; 241:221-225
80. Davis RE, Miller S, Herrnstadt C, Ghosh SS, Fahy E, Shinobu LA, Galasko D, Thal LJ, Beal MF, Howell N, Parker WD: Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc Natl Acad Sci USA 1997; 94:4526-4531
81. Mayeux R, Stern Y, Ottman R, Tatemichi TK, Tang MX, Maestre G, Ngai C, Tycko B, Ginsberg H: The apolipoprotein ε4 allele in patients with Alzheimer's disease. Ann Neurol 1993; 34:752-754